In vitro evaluation of newly developed adsorbent for selective removal of glycosylated low-density lipoprotein

Therapeutic Apheresis

Volumn 6, Issue 6, 2002, Pages 425-430

  Murabayashi, Shun ^a   Nishide, Takuji ^a   Mitamura, Yoshinori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Acrylic acid; Adsorbent; Boronic acid; Diabetes; Dual ligands; Glycosylated low density lipoprotein

Indexed keywords

ACRYLIC ACID; ADSORBENT; BORONIC ACID DERIVATIVE; GLYCOSYLATED LOW DENSITY LIPOPROTEIN; LIGAND; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

APHERESIS; BINDING AFFINITY; CHEMICAL COMPOSITION; CONFERENCE PAPER; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; LIGAND BINDING; PLASMA; POLYMERIZATION; PRIORITY JOURNAL;

ACRYLATES; ADSORPTION; BLOOD COMPONENT REMOVAL; BORONIC ACIDS; GLYCOSYLATION; HUMANS; LIPOPROTEINS, LDL; POLYMERS; VINYL COMPOUNDS;

EID: 0036896145     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00465.x     Document Type: Conference Paper

References (15)

1. Cerami A, Vlassara H, Brownlee M. Glucose and aging. Sci Am 1987;256:90-6.
2. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: Relevance to diabetes mellitus. Science 1978;200:21-7.
3. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
4. Makkita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Fredman AEA, Cerami A. Advanced gylcosylation end products in patients with diabetic nephropathy. N Engl J Med 1994;343:1519-22.
5. Curtiss LK, Witztum JL. Plasma apolipoprotein AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985;34:452-61.
6. Yang CY, Gu ZW, Weng SA, KIM TW, Chen SH, Pownall HJ, Sharp PM, Liu SW, Li WH, Gotto AM, Chan L. Structure of apolipoprotein B-100 of human LDL. Arteriosclerosis 1989;9:96-102.
7. Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 1981;4:121-33.
8. Witzm JL, Mahoney EM, Branks MJ, Fisher M, Elan R, Steinberg D. Nonenzymatic glucosylation of low density lipoprotein alters its biological activity. Diabetes 1982;31:283-1.
9. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylatio: Pathway for lipid oxidation in vivo. Proc Natl Accad Sci USA 1993;90:6433-8.
10. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient? Atherosclerosis 1993;102:63-7.
11. Aviram M. Modified forms of LDL and atherosclerosis. Atherosclerosis 1993;98:1-9.
12. Vlassara H, Bucala R, Striker L. Biology of disease: Pathogenic effects of advanced glycosylation; biochemical, biological, and clinical implications for diabetes and aging. Lab Invest 1994;70:138-51.
13. Letsinger RL, Hamilton SB. Organoboron compounds: X. Popcorn polymers and highly cross-linked vinyl polymers containing boron. J Am Chem Soc 1959;81:3009-12.
14. Zittle CA. Reaction of borate with substances of biological interest. Adv Enzymolecules 1951;12:493-527.
15. Barler ASA, Hatt BW, Somers PJ, Woodbury RR. The use of poly(4-vinylbenzeneboronic acid) resins in the fractionation and interconversion of carbohydrates. Carbohydr Res 1963;26:55-64.